poisar

Stocks · News reference

UBS Maintains Buy on Adient, Lowers Price Target to $29

Aug 6, 2026, 6:55 PMBenzinga Newsdesk

UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $34 to $29.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ADNT
Source
benzinga
Observed
Aug 6, 2026, 6:55 PM
Checked
Aug 6, 2026, 6:55 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 21, 2026, 8:15 PMSEC EDGAR

    8-K filing — Adient plc (ADNT)

    Filed: 2026-08-21 AccNo: 0001670541-26-000100 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

    Read original at edgar
    ADNT